

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.96805755 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.95325073 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.90287207 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.90287207 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.34244544 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.34244544 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.33631685 |
| 8 | glomerular visceral epithelial cell development (GO:0072015) | 5.25301144 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.16696113 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.92869580 |
| 11 | positive regulation of histone deacetylation (GO:0031065) | 4.89983969 |
| 12 | negative T cell selection (GO:0043383) | 4.63030378 |
| 13 | glomerular epithelial cell development (GO:0072310) | 4.60149434 |
| 14 | thymic T cell selection (GO:0045061) | 4.50929856 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.47868076 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.38533199 |
| 17 | positive T cell selection (GO:0043368) | 4.28407297 |
| 18 | T cell selection (GO:0045058) | 4.22854657 |
| 19 | detection of bacterium (GO:0016045) | 4.17917161 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.17480406 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.17480406 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.17480406 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.17480406 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.17480406 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.17480406 |
| 26 | detection of other organism (GO:0098543) | 4.16048779 |
| 27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.89001103 |
| 28 | response to interleukin-15 (GO:0070672) | 3.82802549 |
| 29 | B cell receptor signaling pathway (GO:0050853) | 3.82378701 |
| 30 | interferon-gamma production (GO:0032609) | 3.82342532 |
| 31 | negative regulation of histone methylation (GO:0031061) | 3.70468497 |
| 32 | pre-miRNA processing (GO:0031054) | 3.67414075 |
| 33 | regulation of B cell differentiation (GO:0045577) | 3.64832110 |
| 34 | glomerular basement membrane development (GO:0032836) | 3.63783071 |
| 35 | positive regulation of protein deacetylation (GO:0090312) | 3.62325974 |
| 36 | natural killer cell differentiation (GO:0001779) | 3.58148171 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.55086334 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.52651660 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.52179648 |
| 40 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45559300 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.37342857 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.36048426 |
| 43 | response to peptidoglycan (GO:0032494) | 3.28792408 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.25363160 |
| 45 | T cell receptor signaling pathway (GO:0050852) | 3.23733077 |
| 46 | mannose metabolic process (GO:0006013) | 3.22779238 |
| 47 | tolerance induction (GO:0002507) | 3.21416856 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 3.18403237 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17962782 |
| 50 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17323415 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.16226256 |
| 52 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15077130 |
| 53 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.14969399 |
| 54 | T cell costimulation (GO:0031295) | 3.11633760 |
| 55 | T cell migration (GO:0072678) | 3.11109592 |
| 56 | lymphocyte costimulation (GO:0031294) | 3.02521892 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01558865 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 3.00733852 |
| 59 | nuclear pore complex assembly (GO:0051292) | 3.00679905 |
| 60 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.00456025 |
| 61 | hepatocyte apoptotic process (GO:0097284) | 2.98668532 |
| 62 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.97838972 |
| 63 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.94080070 |
| 64 | cellular extravasation (GO:0045123) | 2.93713765 |
| 65 | cellular response to interleukin-15 (GO:0071350) | 2.92973448 |
| 66 | response to laminar fluid shear stress (GO:0034616) | 2.92334623 |
| 67 | germinal center formation (GO:0002467) | 2.92030348 |
| 68 | respiratory burst (GO:0045730) | 2.90617234 |
| 69 | detection of biotic stimulus (GO:0009595) | 2.90374820 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 2.88879417 |
| 71 | positive regulation of Rap GTPase activity (GO:0032854) | 2.88803177 |
| 72 | regulation of histone H3-K27 methylation (GO:0061085) | 2.88567627 |
| 73 | response to type I interferon (GO:0034340) | 2.86438403 |
| 74 | type I interferon signaling pathway (GO:0060337) | 2.86284314 |
| 75 | cellular response to type I interferon (GO:0071357) | 2.86284314 |
| 76 | histone H3-K36 demethylation (GO:0070544) | 2.85268716 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84611346 |
| 78 | signal complex assembly (GO:0007172) | 2.83613553 |
| 79 | megakaryocyte development (GO:0035855) | 2.81781369 |
| 80 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78040152 |
| 81 | regulation of extracellular matrix disassembly (GO:0010715) | 2.76613649 |
| 82 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.74362876 |
| 83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.73060197 |
| 84 | dosage compensation (GO:0007549) | 2.72660835 |
| 85 | response to host (GO:0075136) | 2.72162939 |
| 86 | response to host defenses (GO:0052200) | 2.72162939 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.72162939 |
| 88 | regulation of mast cell degranulation (GO:0043304) | 2.71999472 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71936840 |
| 90 | negative regulation of T cell mediated immunity (GO:0002710) | 2.71570274 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 2.70977974 |
| 92 | regulation of response to interferon-gamma (GO:0060330) | 2.70944799 |
| 93 | regulation of tolerance induction (GO:0002643) | 2.70081734 |
| 94 | endothelial cell chemotaxis (GO:0035767) | 2.70064989 |
| 95 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.68894475 |
| 96 | negative regulation of phagocytosis (GO:0050765) | 2.68872246 |
| 97 | negative regulation of interleukin-12 production (GO:0032695) | 2.67714392 |
| 98 | negative regulation of stress fiber assembly (GO:0051497) | 2.67510934 |
| 99 | regulation of necroptotic process (GO:0060544) | 2.66949034 |
| 100 | response to host immune response (GO:0052572) | 2.64867426 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64867426 |
| 102 | regulation of defense response to virus by virus (GO:0050690) | 2.64633332 |
| 103 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.63689848 |
| 104 | negative regulation of innate immune response (GO:0045824) | 2.63138822 |
| 105 | modulation by symbiont of host cellular process (GO:0044068) | 2.61479532 |
| 106 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.61120846 |
| 107 | leukocyte aggregation (GO:0070486) | 2.59768864 |
| 108 | myeloid cell activation involved in immune response (GO:0002275) | 2.58702971 |
| 109 | determination of adult lifespan (GO:0008340) | 2.58439124 |
| 110 | modulation by virus of host process (GO:0019054) | 2.57623538 |
| 111 | regulation of T cell tolerance induction (GO:0002664) | 2.57512411 |
| 112 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.56545650 |
| 113 | histone H4-K16 acetylation (GO:0043984) | 2.56418491 |
| 114 | endothelial tube morphogenesis (GO:0061154) | 2.55794388 |
| 115 | morphogenesis of an endothelium (GO:0003159) | 2.55794388 |
| 116 | definitive hemopoiesis (GO:0060216) | 2.55653565 |
| 117 | histone H3-K4 methylation (GO:0051568) | 2.55631890 |
| 118 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.54783488 |
| 119 | positive regulation of tolerance induction (GO:0002645) | 2.53765647 |
| 120 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53510011 |
| 121 | nuclear pore organization (GO:0006999) | 2.52911977 |
| 122 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.52684714 |
| 123 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51973408 |
| 124 | regulation of histone H3-K9 methylation (GO:0051570) | 2.51851028 |
| 125 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.50645639 |
| 126 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.50246338 |
| 127 | neutrophil activation (GO:0042119) | 2.50084967 |
| 128 | embryonic process involved in female pregnancy (GO:0060136) | 2.50053635 |
| 129 | regulation of regulated secretory pathway (GO:1903305) | 2.49884483 |
| 130 | regulation of translational fidelity (GO:0006450) | 2.48494932 |
| 131 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.47886285 |
| 132 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47754950 |
| 133 | regulation of histone deacetylation (GO:0031063) | 2.46941494 |
| 134 | peptidyl-lysine dimethylation (GO:0018027) | 2.46769886 |
| 135 | defense response to protozoan (GO:0042832) | 2.46517517 |
| 136 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.45407255 |
| 137 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.45338111 |
| 138 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.45338111 |
| 139 | heterochromatin organization (GO:0070828) | 2.45240116 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.45014321 |
| 141 | regulation of RNA export from nucleus (GO:0046831) | 2.44619640 |
| 142 | trophectodermal cell differentiation (GO:0001829) | 2.44017098 |
| 143 | activation of JUN kinase activity (GO:0007257) | 2.43929805 |
| 144 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.43766511 |
| 145 | B cell homeostasis (GO:0001782) | 2.43310946 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.42958702 |
| 147 | T cell homeostasis (GO:0043029) | 2.41946093 |
| 148 | DNA duplex unwinding (GO:0032508) | 2.41764633 |
| 149 | angiogenesis involved in wound healing (GO:0060055) | 2.41661656 |
| 150 | cellular response to virus (GO:0098586) | 2.41572654 |
| 151 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.41434614 |
| 152 | V(D)J recombination (GO:0033151) | 2.41183859 |
| 153 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.39968487 |
| 154 | protein localization to endosome (GO:0036010) | 2.39882495 |
| 155 | adherens junction assembly (GO:0034333) | 2.39858480 |
| 156 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.39270431 |
| 157 | histone H3-K4 trimethylation (GO:0080182) | 2.38086264 |
| 158 | DNA geometric change (GO:0032392) | 2.37917417 |
| 159 | leukocyte cell-cell adhesion (GO:0007159) | 2.37553423 |
| 160 | positive regulation of lamellipodium assembly (GO:0010592) | 2.37503610 |
| 161 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.37098562 |
| 162 | cellular hyperosmotic response (GO:0071474) | 2.36994922 |
| 163 | focal adhesion assembly (GO:0048041) | 2.35634496 |
| 164 | cell-substrate adherens junction assembly (GO:0007045) | 2.35634496 |
| 165 | embryonic placenta development (GO:0001892) | 2.32075172 |
| 166 | negative regulation of bone resorption (GO:0045779) | 2.31769017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.70409380 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.39061660 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.14443388 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.88491584 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.26075360 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19345820 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.91440253 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.68110120 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.51943396 |
| 10 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.48426657 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.44892487 |
| 12 | MAF_26560356_Chip-Seq_TH1_Human | 2.41229295 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 2.39295019 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.39149498 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.38644726 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.38017723 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.34303067 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.32964162 |
| 19 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.32216718 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22812571 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.12519168 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.10353293 |
| 23 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08992968 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02040436 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89652352 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86286624 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81112565 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75885876 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.71901541 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71744548 |
| 31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.70274136 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69125428 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68510668 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63253018 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61806602 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60916925 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60627246 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60154474 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60037726 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59782841 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.58120845 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.52764847 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51774992 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48345190 |
| 45 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.48186246 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42207338 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40105495 |
| 48 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.36757725 |
| 49 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34754414 |
| 50 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.34404661 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33273164 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31734397 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31173400 |
| 54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30990797 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28072391 |
| 56 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.27777664 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27457911 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26287815 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25838249 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23986086 |
| 61 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23879809 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23730570 |
| 63 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.22644112 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21932717 |
| 65 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21697338 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19414374 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18953758 |
| 68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18848279 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18704377 |
| 70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18294682 |
| 71 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17691905 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17508500 |
| 73 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.16052686 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15482954 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14657002 |
| 76 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.14427635 |
| 77 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14224066 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13766347 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13339263 |
| 80 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.11869067 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10864781 |
| 82 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09102417 |
| 83 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09047971 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07956876 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07173173 |
| 86 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07129438 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06626819 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06089592 |
| 89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05695848 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05590215 |
| 91 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05053405 |
| 92 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05024727 |
| 93 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04775701 |
| 94 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04464926 |
| 95 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04074095 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02857140 |
| 97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01635172 |
| 98 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00554900 |
| 99 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00387480 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00255995 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99976473 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99462659 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98368261 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97266810 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96120706 |
| 106 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.95862722 |
| 107 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95845740 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.95455624 |
| 109 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95324879 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94358245 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94050102 |
| 112 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.93408015 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93170011 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93135583 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.92984122 |
| 116 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92555864 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91550897 |
| 118 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91345421 |
| 119 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91216490 |
| 120 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.90075291 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89102779 |
| 122 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88491692 |
| 123 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88015893 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87303668 |
| 125 | * P68_20966046_ChIP-Seq_HELA_Human | 0.86114534 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85906970 |
| 127 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85290586 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84838579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.62528040 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.24146809 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.81516587 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.63296830 |
| 5 | MP0003724_increased_susceptibility_to | 2.60225197 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.55844798 |
| 7 | MP0008260_abnormal_autophagy | 2.51111427 |
| 8 | MP0000685_abnormal_immune_system | 2.45839280 |
| 9 | MP0001800_abnormal_humoral_immune | 2.41510490 |
| 10 | MP0004808_abnormal_hematopoietic_stem | 2.40546016 |
| 11 | MP0005451_abnormal_body_composition | 2.40298552 |
| 12 | MP0001873_stomach_inflammation | 2.36354918 |
| 13 | MP0002398_abnormal_bone_marrow | 2.31830049 |
| 14 | MP0008961_abnormal_basal_metabolism | 2.22536141 |
| 15 | MP0005671_abnormal_response_to | 2.15234127 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.14420791 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.06637726 |
| 18 | MP0005387_immune_system_phenotype | 2.06526959 |
| 19 | MP0001790_abnormal_immune_system | 2.06526959 |
| 20 | MP0000703_abnormal_thymus_morphology | 2.05678392 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.04115360 |
| 22 | MP0009278_abnormal_bone_marrow | 2.01461816 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.01296567 |
| 24 | MP0000689_abnormal_spleen_morphology | 1.99763233 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.99724550 |
| 26 | MP0009840_abnormal_foam_cell | 1.95200126 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.94719043 |
| 28 | MP0002722_abnormal_immune_system | 1.93563974 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.90182787 |
| 30 | MP0000716_abnormal_immune_system | 1.86104414 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 1.84209373 |
| 32 | MP0001545_abnormal_hematopoietic_system | 1.84209373 |
| 33 | MP0001819_abnormal_immune_cell | 1.83877224 |
| 34 | MP0002006_tumorigenesis | 1.83745331 |
| 35 | MP0003303_peritoneal_inflammation | 1.82035315 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.76547892 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.70736363 |
| 38 | MP0009785_altered_susceptibility_to | 1.67991945 |
| 39 | MP0002723_abnormal_immune_serum | 1.66373904 |
| 40 | MP0002429_abnormal_blood_cell | 1.64641574 |
| 41 | MP0006082_CNS_inflammation | 1.64112855 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.63764903 |
| 43 | MP0004947_skin_inflammation | 1.63331838 |
| 44 | MP0003866_abnormal_defecation | 1.62323383 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.58630052 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.55373711 |
| 47 | MP0004381_abnormal_hair_follicle | 1.54497721 |
| 48 | MP0005023_abnormal_wound_healing | 1.49619351 |
| 49 | MP0005409_darkened_coat_color | 1.44309767 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.43994743 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.42714423 |
| 52 | MP0010307_abnormal_tumor_latency | 1.42333351 |
| 53 | MP0002405_respiratory_system_inflammati | 1.36376318 |
| 54 | MP0003091_abnormal_cell_migration | 1.35364940 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.35277829 |
| 56 | MP0000858_altered_metastatic_potential | 1.32991686 |
| 57 | MP0003045_fibrosis | 1.31542165 |
| 58 | MP0000490_abnormal_crypts_of | 1.30114750 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.28939611 |
| 60 | MP0004264_abnormal_extraembryonic_tissu | 1.28021651 |
| 61 | MP0001851_eye_inflammation | 1.26822920 |
| 62 | MP0003077_abnormal_cell_cycle | 1.25979904 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.25926852 |
| 64 | MP0008057_abnormal_DNA_replication | 1.25338018 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.24298101 |
| 66 | MP0002136_abnormal_kidney_physiology | 1.22962125 |
| 67 | MP0006054_spinal_hemorrhage | 1.22320799 |
| 68 | MP0003828_pulmonary_edema | 1.21383876 |
| 69 | MP0002086_abnormal_extraembryonic_tissu | 1.21382198 |
| 70 | MP0002009_preneoplasia | 1.14766225 |
| 71 | MP0005310_abnormal_salivary_gland | 1.12450724 |
| 72 | MP0003436_decreased_susceptibility_to | 1.12373613 |
| 73 | MP0001348_abnormal_lacrimal_gland | 1.11971961 |
| 74 | MP0001845_abnormal_inflammatory_respons | 1.10874666 |
| 75 | MP0005025_abnormal_response_to | 1.10351875 |
| 76 | MP0001730_embryonic_growth_arrest | 1.09281395 |
| 77 | MP0004858_abnormal_nervous_system | 1.08911029 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.08556369 |
| 79 | MP0008469_abnormal_protein_level | 1.08160733 |
| 80 | MP0002796_impaired_skin_barrier | 1.07271640 |
| 81 | MP0003111_abnormal_nucleus_morphology | 1.06665066 |
| 82 | MP0003279_aneurysm | 1.05274459 |
| 83 | MP0000477_abnormal_intestine_morphology | 1.04926373 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.04713630 |
| 85 | MP0004510_myositis | 1.03917878 |
| 86 | MP0003329_amyloid_beta_deposits | 1.03880578 |
| 87 | MP0000350_abnormal_cell_proliferation | 1.02950847 |
| 88 | MP0001958_emphysema | 1.01494112 |
| 89 | MP0010094_abnormal_chromosome_stability | 1.00143381 |
| 90 | MP0004957_abnormal_blastocyst_morpholog | 0.98981410 |
| 91 | MP0003448_altered_tumor_morphology | 0.98102518 |
| 92 | MP0000604_amyloidosis | 0.96555787 |
| 93 | MP0003984_embryonic_growth_retardation | 0.94940913 |
| 94 | MP0002088_abnormal_embryonic_growth/wei | 0.93517523 |
| 95 | MP0005670_abnormal_white_adipose | 0.93420390 |
| 96 | MP0002132_abnormal_respiratory_system | 0.92846867 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.92201893 |
| 98 | MP0005166_decreased_susceptibility_to | 0.92196729 |
| 99 | MP0001661_extended_life_span | 0.91761719 |
| 100 | MP0004197_abnormal_fetal_growth/weight/ | 0.91550233 |
| 101 | MP0002933_joint_inflammation | 0.91422549 |
| 102 | MP0000609_abnormal_liver_physiology | 0.90685406 |
| 103 | MP0005380_embryogenesis_phenotype | 0.90420351 |
| 104 | MP0001672_abnormal_embryogenesis/_devel | 0.90420351 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.90187773 |
| 106 | MP0002084_abnormal_developmental_patter | 0.90045081 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.89987463 |
| 108 | MP0002925_abnormal_cardiovascular_devel | 0.89301592 |
| 109 | MP0005623_abnormal_meninges_morphology | 0.88600650 |
| 110 | MP0008770_decreased_survivor_rate | 0.88118802 |
| 111 | MP0001849_ear_inflammation | 0.88006717 |
| 112 | MP0002135_abnormal_kidney_morphology | 0.87628005 |
| 113 | MP0001663_abnormal_digestive_system | 0.85278089 |
| 114 | MP0003191_abnormal_cellular_cholesterol | 0.84736950 |
| 115 | MP0001915_intracranial_hemorrhage | 0.83941852 |
| 116 | MP0005501_abnormal_skin_physiology | 0.83451460 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.83221649 |
| 118 | MP0004883_abnormal_blood_vessel | 0.81648014 |
| 119 | MP0001853_heart_inflammation | 0.80602599 |
| 120 | MP0001697_abnormal_embryo_size | 0.78875092 |
| 121 | MP0002080_prenatal_lethality | 0.78804492 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.78544280 |
| 123 | MP0003787_abnormal_imprinting | 0.78458301 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.78321919 |
| 125 | MP0002928_abnormal_bile_duct | 0.78293204 |
| 126 | MP0003075_altered_response_to | 0.77952792 |
| 127 | MP0001784_abnormal_fluid_regulation | 0.76261935 |
| 128 | MP0004130_abnormal_muscle_cell | 0.76045996 |
| 129 | MP0005621_abnormal_cell_physiology | 0.75661363 |
| 130 | MP0000015_abnormal_ear_pigmentation | 0.75609809 |
| 131 | MP0002419_abnormal_innate_immunity | 0.75353859 |
| 132 | MP0005390_skeleton_phenotype | 0.73230791 |
| 133 | MP0000598_abnormal_liver_morphology | 0.72525965 |
| 134 | MP0002138_abnormal_hepatobiliary_system | 0.71509054 |
| 135 | MP0005365_abnormal_bile_salt | 0.70974487 |
| 136 | MP0008874_decreased_physiological_sensi | 0.70480485 |
| 137 | MP0000537_abnormal_urethra_morphology | 0.70125245 |
| 138 | MP0000249_abnormal_blood_vessel | 0.69856961 |
| 139 | MP0001216_abnormal_epidermal_layer | 0.68768555 |
| 140 | MP0009931_abnormal_skin_appearance | 0.68246419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.48794775 |
| 2 | Abnormality of the fingertips (HP:0001211) | 4.22112584 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.97032430 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.92751746 |
| 5 | T lymphocytopenia (HP:0005403) | 3.87058045 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.80395615 |
| 7 | Recurrent bronchitis (HP:0002837) | 3.67849318 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.52287174 |
| 9 | Myositis (HP:0100614) | 3.30740687 |
| 10 | Agammaglobulinemia (HP:0004432) | 3.20495738 |
| 11 | Recurrent viral infections (HP:0004429) | 3.19327979 |
| 12 | Mesangial abnormality (HP:0001966) | 3.18068365 |
| 13 | Chronic otitis media (HP:0000389) | 3.17284718 |
| 14 | Verrucae (HP:0200043) | 3.16649764 |
| 15 | Papilloma (HP:0012740) | 3.16649764 |
| 16 | IgM deficiency (HP:0002850) | 3.14952194 |
| 17 | Cerebral aneurysm (HP:0004944) | 3.03705488 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03619402 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 2.99843727 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 2.95681225 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95064959 |
| 22 | Gingivitis (HP:0000230) | 2.88592110 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.87464771 |
| 24 | Abnormality of T cells (HP:0002843) | 2.87236533 |
| 25 | Gastrointestinal inflammation (HP:0004386) | 2.85496400 |
| 26 | Basal cell carcinoma (HP:0002671) | 2.85114325 |
| 27 | Orchitis (HP:0100796) | 2.84173409 |
| 28 | Hyperacusis (HP:0010780) | 2.83265679 |
| 29 | Inflammation of the large intestine (HP:0002037) | 2.81426599 |
| 30 | Aortic aneurysm (HP:0004942) | 2.80697138 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 2.79240300 |
| 32 | Obstructive lung disease (HP:0006536) | 2.78495554 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78495554 |
| 34 | Colitis (HP:0002583) | 2.77748598 |
| 35 | Cellulitis (HP:0100658) | 2.73522514 |
| 36 | Nasal polyposis (HP:0100582) | 2.72424882 |
| 37 | Pustule (HP:0200039) | 2.72216654 |
| 38 | Focal segmental glomerulosclerosis (HP:0000097) | 2.68314775 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.67479777 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.67235869 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.64129611 |
| 42 | Recurrent skin infections (HP:0001581) | 2.62923744 |
| 43 | Abnormal platelet volume (HP:0011876) | 2.57315285 |
| 44 | Thin bony cortex (HP:0002753) | 2.57150545 |
| 45 | Broad face (HP:0000283) | 2.53729939 |
| 46 | Vasculitis (HP:0002633) | 2.45774345 |
| 47 | Lymphopenia (HP:0001888) | 2.43875328 |
| 48 | Recurrent fungal infections (HP:0002841) | 2.37284858 |
| 49 | Malnutrition (HP:0004395) | 2.35270035 |
| 50 | Abnormality of oral frenula (HP:0000190) | 2.34129071 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.33420881 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.33378861 |
| 53 | Macroorchidism (HP:0000053) | 2.33378472 |
| 54 | Increased mean platelet volume (HP:0011877) | 2.33169155 |
| 55 | Osteomyelitis (HP:0002754) | 2.33160849 |
| 56 | Ulnar bowing (HP:0003031) | 2.29506775 |
| 57 | Optic neuritis (HP:0100653) | 2.26568486 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.26568486 |
| 59 | Urticaria (HP:0001025) | 2.24190988 |
| 60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23075997 |
| 61 | Heterotopia (HP:0002282) | 2.20999361 |
| 62 | Glomerulosclerosis (HP:0000096) | 2.20391334 |
| 63 | Combined immunodeficiency (HP:0005387) | 2.20388253 |
| 64 | Stomatitis (HP:0010280) | 2.20139781 |
| 65 | Vertebral arch anomaly (HP:0008438) | 2.19442947 |
| 66 | Hypoalbuminemia (HP:0003073) | 2.18404208 |
| 67 | Abnormal albumin level (HP:0012116) | 2.18404208 |
| 68 | Slow saccadic eye movements (HP:0000514) | 2.17121137 |
| 69 | Ependymoma (HP:0002888) | 2.14431595 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.12563202 |
| 71 | Thrombocytosis (HP:0001894) | 2.09448777 |
| 72 | Polygenic inheritance (HP:0010982) | 2.06633357 |
| 73 | Thyroiditis (HP:0100646) | 2.04626009 |
| 74 | Subacute progressive viral hepatitis (HP:0006572) | 2.03940470 |
| 75 | Encephalitis (HP:0002383) | 2.03606005 |
| 76 | Emphysema (HP:0002097) | 2.02984091 |
| 77 | Hematochezia (HP:0002573) | 2.01018788 |
| 78 | Broad palm (HP:0001169) | 2.00957540 |
| 79 | Aneurysm (HP:0002617) | 2.00519493 |
| 80 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.99784391 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 1.98774260 |
| 82 | Obstructive sleep apnea (HP:0002870) | 1.98606696 |
| 83 | Flat acetabular roof (HP:0003180) | 1.97829097 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 1.96344009 |
| 85 | Sepsis (HP:0100806) | 1.95095152 |
| 86 | Bronchitis (HP:0012387) | 1.93983602 |
| 87 | Mitral valve prolapse (HP:0001634) | 1.93587645 |
| 88 | Skin ulcer (HP:0200042) | 1.92388811 |
| 89 | Papilledema (HP:0001085) | 1.91837046 |
| 90 | Increased density of long bones (HP:0006392) | 1.90146045 |
| 91 | Gastrointestinal stroma tumor (HP:0100723) | 1.89675914 |
| 92 | Abnormality of the lower motor neuron (HP:0002366) | 1.89470236 |
| 93 | Granulocytopenia (HP:0001913) | 1.89321604 |
| 94 | Restrictive lung disease (HP:0002091) | 1.88129037 |
| 95 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.87131770 |
| 96 | Short 4th metacarpal (HP:0010044) | 1.87131770 |
| 97 | Amyloidosis (HP:0011034) | 1.86559142 |
| 98 | Severe combined immunodeficiency (HP:0004430) | 1.86469830 |
| 99 | Meningitis (HP:0001287) | 1.85958778 |
| 100 | Long eyelashes (HP:0000527) | 1.85714335 |
| 101 | Hypochromic anemia (HP:0001931) | 1.84375116 |
| 102 | Pulmonary infiltrates (HP:0002113) | 1.84152860 |
| 103 | Petechiae (HP:0000967) | 1.83647383 |
| 104 | Gingival bleeding (HP:0000225) | 1.83108698 |
| 105 | Abnormal foot bone ossification (HP:0010675) | 1.83071756 |
| 106 | Dysostosis multiplex (HP:0000943) | 1.81015754 |
| 107 | Hypoplasia of the thymus (HP:0000778) | 1.79408855 |
| 108 | Premature loss of primary teeth (HP:0006323) | 1.78937047 |
| 109 | Ankle contracture (HP:0006466) | 1.78502553 |
| 110 | Persistence of primary teeth (HP:0006335) | 1.78040579 |
| 111 | Distal lower limb amyotrophy (HP:0008944) | 1.77452780 |
| 112 | Dilatation of the ascending aorta (HP:0005111) | 1.77149655 |
| 113 | Volvulus (HP:0002580) | 1.77084877 |
| 114 | Poikiloderma (HP:0001029) | 1.76871584 |
| 115 | Recurrent sinusitis (HP:0011108) | 1.75756167 |
| 116 | Peritonitis (HP:0002586) | 1.75128985 |
| 117 | Increased cerebral lipofuscin (HP:0011813) | 1.75092492 |
| 118 | Ureteral stenosis (HP:0000071) | 1.74435125 |
| 119 | Selective tooth agenesis (HP:0001592) | 1.74256757 |
| 120 | Resting tremor (HP:0002322) | 1.73636529 |
| 121 | Epistaxis (HP:0000421) | 1.71889774 |
| 122 | Bicuspid aortic valve (HP:0001647) | 1.71398478 |
| 123 | Nephritis (HP:0000123) | 1.71386517 |
| 124 | Biliary tract neoplasm (HP:0100574) | 1.71354869 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.68837890 |
| 126 | Spinal cord lesions (HP:0100561) | 1.68786059 |
| 127 | Syringomyelia (HP:0003396) | 1.68786059 |
| 128 | Elfin facies (HP:0004428) | 1.68785861 |
| 129 | Increased connective tissue (HP:0009025) | 1.68598365 |
| 130 | Keratoconjunctivitis sicca (HP:0001097) | 1.68277525 |
| 131 | Bowed forearm bones (HP:0003956) | 1.68151488 |
| 132 | Bowing of the arm (HP:0006488) | 1.68151488 |
| 133 | Increased IgE level (HP:0003212) | 1.67178159 |
| 134 | Purpura (HP:0000979) | 1.66975494 |
| 135 | Abnormality of B cell number (HP:0010975) | 1.66921498 |
| 136 | B lymphocytopenia (HP:0010976) | 1.66921498 |
| 137 | Hypergammaglobulinemia (HP:0010702) | 1.66684202 |
| 138 | Narrow palate (HP:0000189) | 1.66255355 |
| 139 | Chest pain (HP:0100749) | 1.65980935 |
| 140 | Loss of speech (HP:0002371) | 1.65841110 |
| 141 | Recurrent otitis media (HP:0000403) | 1.65165413 |
| 142 | Hemoptysis (HP:0002105) | 1.65145776 |
| 143 | Disproportionate tall stature (HP:0001519) | 1.64811753 |
| 144 | Hypertriglyceridemia (HP:0002155) | 1.64688797 |
| 145 | Easy fatigability (HP:0003388) | 1.64044980 |
| 146 | Annular pancreas (HP:0001734) | 1.63249241 |
| 147 | Metaphyseal cupping (HP:0003021) | 1.62266406 |
| 148 | Cervical subluxation (HP:0003308) | 1.62122742 |
| 149 | Arterial thrombosis (HP:0004420) | 1.61428939 |
| 150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.61069274 |
| 151 | Recurrent cutaneous fungal infections (HP:0011370) | 1.61069274 |
| 152 | Spastic diplegia (HP:0001264) | 1.60999294 |
| 153 | Gastrointestinal carcinoma (HP:0002672) | 1.60591850 |
| 154 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.60591850 |
| 155 | Bowel diverticulosis (HP:0005222) | 1.59858932 |
| 156 | Skin tags (HP:0010609) | 1.59855337 |
| 157 | Hypoproteinemia (HP:0003075) | 1.59570283 |
| 158 | Viral hepatitis (HP:0006562) | 1.59233091 |
| 159 | Impaired platelet aggregation (HP:0003540) | 1.59093096 |
| 160 | Abnormal platelet function (HP:0011869) | 1.59093096 |
| 161 | Lymphoma (HP:0002665) | 1.57854065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.59672134 |
| 2 | PRPF4B | 3.90883155 |
| 3 | MAP3K10 | 3.72825176 |
| 4 | EEF2K | 3.62493294 |
| 5 | GRK6 | 3.03141785 |
| 6 | CDK12 | 3.01038624 |
| 7 | PKN2 | 2.79048743 |
| 8 | TRIB3 | 2.77038135 |
| 9 | STK10 | 2.73082509 |
| 10 | SMG1 | 2.59489410 |
| 11 | ERN1 | 2.31355161 |
| 12 | FGFR4 | 2.16520349 |
| 13 | LRRK2 | 2.01670614 |
| 14 | BLK | 1.97870577 |
| 15 | JAK3 | 1.92731549 |
| 16 | IRAK4 | 1.88857731 |
| 17 | ITK | 1.76330965 |
| 18 | TTN | 1.69829123 |
| 19 | FLT3 | 1.67931266 |
| 20 | ZAP70 | 1.61007344 |
| 21 | FGFR3 | 1.55589016 |
| 22 | MAP3K3 | 1.50255850 |
| 23 | TGFBR2 | 1.49286304 |
| 24 | SIK3 | 1.48651779 |
| 25 | RIPK1 | 1.45257975 |
| 26 | MAP3K7 | 1.44232281 |
| 27 | BTK | 1.42731828 |
| 28 | PTK6 | 1.40471656 |
| 29 | MAP3K11 | 1.36677976 |
| 30 | TYK2 | 1.36491469 |
| 31 | MAP3K13 | 1.34685119 |
| 32 | JAK1 | 1.34259924 |
| 33 | TXK | 1.32190355 |
| 34 | CSF1R | 1.30036061 |
| 35 | RPS6KB2 | 1.28634274 |
| 36 | MAP3K1 | 1.27926379 |
| 37 | MAP3K14 | 1.27118043 |
| 38 | SIK1 | 1.26504279 |
| 39 | CSK | 1.22000193 |
| 40 | TYRO3 | 1.21916599 |
| 41 | SIK2 | 1.18118145 |
| 42 | KSR2 | 1.17868542 |
| 43 | BRD4 | 1.17706791 |
| 44 | PDGFRA | 1.14620999 |
| 45 | PAK4 | 1.14413943 |
| 46 | TESK2 | 1.12904313 |
| 47 | MAP2K3 | 1.11851525 |
| 48 | IRAK3 | 1.08687447 |
| 49 | CDK4 | 1.07241886 |
| 50 | HCK | 1.04327329 |
| 51 | ALK | 1.01476883 |
| 52 | PIM1 | 1.00529342 |
| 53 | LCK | 0.98966070 |
| 54 | TAOK2 | 0.94414807 |
| 55 | PRKD2 | 0.93744569 |
| 56 | PRKCH | 0.93314729 |
| 57 | KIT | 0.93160596 |
| 58 | CDC42BPA | 0.91443147 |
| 59 | PDPK1 | 0.90897983 |
| 60 | SYK | 0.90489240 |
| 61 | CDK6 | 0.88276582 |
| 62 | MTOR | 0.87570844 |
| 63 | FGR | 0.84796545 |
| 64 | IKBKE | 0.83965511 |
| 65 | PDGFRB | 0.82134621 |
| 66 | EPHA2 | 0.81882627 |
| 67 | MARK2 | 0.80342279 |
| 68 | TNK2 | 0.79622215 |
| 69 | MST1R | 0.79513358 |
| 70 | IRAK2 | 0.77885314 |
| 71 | JAK2 | 0.75860058 |
| 72 | CAMK1D | 0.75543848 |
| 73 | FGFR2 | 0.74886256 |
| 74 | TAOK1 | 0.73132586 |
| 75 | MAP3K6 | 0.72057096 |
| 76 | SGK3 | 0.71553840 |
| 77 | MAPK12 | 0.69640062 |
| 78 | MARK3 | 0.69107262 |
| 79 | CAMKK1 | 0.68635072 |
| 80 | HIPK2 | 0.68571670 |
| 81 | MAP3K8 | 0.68259465 |
| 82 | NEK2 | 0.65200361 |
| 83 | PASK | 0.63759144 |
| 84 | PDK1 | 0.62575154 |
| 85 | ARAF | 0.62317182 |
| 86 | RET | 0.60733218 |
| 87 | TRPM7 | 0.60513422 |
| 88 | MST4 | 0.59785441 |
| 89 | RPS6KA2 | 0.59775302 |
| 90 | TEC | 0.58942387 |
| 91 | CAMK1G | 0.56553553 |
| 92 | CLK1 | 0.55542435 |
| 93 | CDK9 | 0.54680744 |
| 94 | TGFBR1 | 0.54538483 |
| 95 | MAPKAPK3 | 0.52340708 |
| 96 | YES1 | 0.51105373 |
| 97 | PRKG2 | 0.51034821 |
| 98 | STK4 | 0.50667431 |
| 99 | MAP3K2 | 0.50082717 |
| 100 | MAPK11 | 0.49844302 |
| 101 | CDC7 | 0.49763670 |
| 102 | STK38 | 0.49568137 |
| 103 | FYN | 0.49523736 |
| 104 | MELK | 0.49432676 |
| 105 | PTK2 | 0.48842060 |
| 106 | ICK | 0.48817068 |
| 107 | NLK | 0.47270775 |
| 108 | MAPK7 | 0.47172810 |
| 109 | BMX | 0.45512399 |
| 110 | EPHB1 | 0.45414295 |
| 111 | PRKCQ | 0.44220947 |
| 112 | MAP2K2 | 0.43718666 |
| 113 | MAPK15 | 0.43704556 |
| 114 | CDK7 | 0.43469430 |
| 115 | DYRK1B | 0.43261695 |
| 116 | LMTK2 | 0.42975965 |
| 117 | RPS6KC1 | 0.42958205 |
| 118 | RPS6KL1 | 0.42958205 |
| 119 | RPS6KA6 | 0.42359282 |
| 120 | FGFR1 | 0.42321819 |
| 121 | IRAK1 | 0.41107734 |
| 122 | RIPK4 | 0.40797721 |
| 123 | IKBKB | 0.40193068 |
| 124 | ATR | 0.40108763 |
| 125 | TBK1 | 0.39156934 |
| 126 | CHUK | 0.38273159 |
| 127 | CAMK4 | 0.38179766 |
| 128 | STK11 | 0.37616449 |
| 129 | FES | 0.34546256 |
| 130 | CHEK1 | 0.34370527 |
| 131 | LYN | 0.33197202 |
| 132 | RPS6KA4 | 0.32889427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.68902342 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.55581663 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.14513924 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.12508629 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.93879120 |
| 6 | Lysine degradation_Homo sapiens_hsa00310 | 1.85085148 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.75204669 |
| 8 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.73176061 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69691965 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.66706002 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61224097 |
| 12 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.60415011 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59866960 |
| 14 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.59731255 |
| 15 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.59260226 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54810564 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54046806 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53972631 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53813267 |
| 20 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.51700160 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.48778482 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48005021 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.45690193 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40766625 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.34022525 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30723316 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30295068 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24405156 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.23935135 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19491572 |
| 31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19082179 |
| 32 | Colorectal cancer_Homo sapiens_hsa05210 | 1.16260010 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15009187 |
| 34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13255539 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11127527 |
| 36 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11036721 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10857627 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10854664 |
| 39 | Focal adhesion_Homo sapiens_hsa04510 | 1.09761886 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08075728 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06892031 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06042803 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 1.05967295 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 1.03993220 |
| 45 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.01837934 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00804212 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.99063042 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.98152821 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97972233 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97484684 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.95922264 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95766715 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95175157 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.93119183 |
| 55 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92298414 |
| 56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90008766 |
| 57 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.89563928 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.89357139 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88931347 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87936731 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.86286243 |
| 62 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86087632 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.85264778 |
| 64 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85058868 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84600815 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84022534 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.82885836 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81639406 |
| 69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80303077 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.79875669 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79649730 |
| 72 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79445454 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76732057 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.76692534 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.75307462 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75296470 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.75020788 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74971986 |
| 79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73574402 |
| 80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72141164 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.71392908 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.71371380 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.71171737 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69652823 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.69479584 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.68851043 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68555097 |
| 88 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67863567 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67353048 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.67336431 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66885421 |
| 92 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.65663443 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64919027 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.63983847 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63526670 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63028499 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.62652812 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.61665279 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61146686 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.60480994 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60274253 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60144525 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59721977 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58764984 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58401064 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.57710785 |
| 107 | ABC transporters_Homo sapiens_hsa02010 | 0.57657422 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.56763745 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.56544603 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56435446 |
| 111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56038473 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54871106 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54313866 |
| 114 | Mismatch repair_Homo sapiens_hsa03430 | 0.54210403 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54124093 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.53837163 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52360652 |
| 118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51362242 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51214171 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51206210 |
| 121 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49998524 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48263183 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47356853 |
| 124 | Base excision repair_Homo sapiens_hsa03410 | 0.47104906 |
| 125 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46400553 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46014754 |
| 127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45665170 |

